We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaboration to Assess Imaging Systems in India

By MedImaging staff writers
Posted on 12 Jul 2006
GE Healthcare (Chalfont St. More...
Giles, UK) is opening its first Integrated Development Center (IDC) at Manipal Hospital (Bangalore, India), as part of the strategic development of its Global Clinical Studies Program.

The IDC in Bangalore is expected to conduct approximately 1,000 medical imaging scans yearly as part of the planned clinical trials and will be part of a series of global multi-country clinical studies in the United States, the European Union, and several other countries. Over time, GE Healthcare will create more IDCs in major strategic locations globally.

Data obtained from this site will be combined with information from other centers worldwide and contribute towards the development of new contrast and molecular imaging agents or new indications for existing agents. The first studies will focus on Visipaque (iodixanol), an isosmolar contrast agent that was launched globally by GE Healthcare in 1996.

Under the terms of the collaboration, physicians at Manipal Hospital will act as study investigators and provide clinical and imaging services and administration in the hospital. The IDC in Bangalore will play a critical role in GE Healthcare's ongoing global clinical research program and support its vision of "early health” by helping to bring new diagnostic imaging agents to market and working to address serious unmet medical needs in oncology, neurology, and cardiology.

V. Raja, president, GE Healthcare India, commented, "We are extremely pleased to collaborate with Manipal Hospital which is one of India's most respected institutions. GE Healthcare and Manipal Hospital are both driven by a desire to change the future of healthcare by helping patients experience "early health,” which focuses on early diagnosis rather than late disease. Together, we will be able to create one of the most advanced Integrated Development Centers in the world. We will also be tapping into the resources of the GE Global Research Center here in Bangalore, as well the expertise of our global Medical Diagnostics team.”

Manipal Health Systems has three tertiary care hospital located at the hubs, nine secondary care hospitals, 19 primary healthcare Centers, seven rural welfare centers, complimentary clinics at Bangalore International Airport and Mangalore domestic airport, and over 55 community development projects.



Related Links:
GE Healthcare
Manipal Hospital

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.